Sequana Medical NV

Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. Show More...

  • Website https://www.sequanamedical.com
  • Sector Healthcare
  • Industry Medical Devices
  • Last Quote 1.02 EUR
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share EUR -0.85 -1.02 -0.6 -1.02 -1.22 -1.22
    Dividends EUR
    Payout Ratio % *
    Shares Mil 14.0 14.0 14.0 14.0 12.0 13.0
    Book Value Per Share * EUR 0.68 0.07
    Free Cash Flow Per Share * EUR -1.44
    Return on Assets % -215.53 -329.24 -224.53 -407.65 -236.03 -236.03
    Financial Leverage (Average) 10.1 10.1
    Return on Equity % -901.39
    Return on Invested Capital % -897.05
    Interest Coverage -129.06 -72.3 -11.91 -14.14 -18.26 -18.26
    Current Ratio 1.07 0.7 0.58 0.17 1.6 1.6
    Quick Ratio 0.49 0.28 0.36 0.09 1.17 1.17
    Debt/Equity 2.77 2.77